What was the year‑over‑year growth rate for revenue and net income in Q2 2025?

Answer

The press‑release excerpt you supplied does not include the actual revenue or net‑income figures for Q2 2025, so the year‑over‑year (YoY) growth rates for those line items cannot be calculated from the information given. Profound Medical’s full earnings release (or the SEC Form 10‑Q) will list the Q2 2025 revenue and net‑income amounts together with the comparable Q2 2024 results, from which the YoY growth percentages can be derived.

Trading implications (assuming the typical scenario of strong YoY growth)

If the company reported double‑digit YoY revenue growth and a sizable increase in net income, the market would likely price in higher expectations for future sales of its AI‑powered, incision‑free ablation platforms. In that case, a bullish stance—such as buying on any pull‑back or adding to existing positions—could be justified, especially if the stock is still trading below its 52‑week high and the technical trend remains upward (e.g., price above the 20‑day EMA, higher‑highs/lower‑lows). Conversely, if the YoY growth rates are modest or negative, the stock may face pressure, and a defensive approach (tightening stops or reducing exposure) would be prudent.

Next step: Retrieve the complete Q2 2025 earnings release (or the company’s 10‑Q filing) to obtain the exact revenue and net‑income numbers, compute the YoY growth rates, and then align your trade‑size and risk management with the confirmed fundamentals.